In the first of four 2025 BBC Reith Lectures, recorded in London, the Dutch historian Rutger Bregman asks what can be done to counter the moral decay of today's un-serious elites. Show more Rutger ...

Coinbase is adding another Solana-focused piece to its growing trading empire with the acquisition of Vector, an on-chain trading platform built natively for Solana’s high-speed environment. The ...

Lectures on Tap series brings professors and other experts into Boston restaurants and bars for talks that mix big ideas with food and drink. Lectures on Tap, an event series, brings ticketed lectures ...

When Aquant Inc. was looking to build its platform — an artificial intelligence service that supports field technicians and agents teams with an AI-powered copilot to provide personalized ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Three of Yale’s most esteemed historians will team up next fall to teach a course exploring the nature of American identity from 1776 to the present as part of the 2025 DeVane Lecture course, an ...

Abstract: Vector Calculus is an important topic in a typical engineering mathematics curriculum. Acquiring both conceptual and procedural knowledge in this abstract topic is required to understand and ...

One of the more exciting features to come with The Sims 4 Businesses and Hobbies Expansion Pack is the ability to lead a lecture or a class. While you can leisurely run a lecture for Sims to boost ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

If you’ve opened the Notes app on your iPhone recently, only to find every entry is missing, you’ve come across a “scary bug” which seems to have been widespread. Apple has now commented on this ...

Guided by standardized production and purification platforms, developers of monoclonal antibodies (mAbs) and other recombinant-protein therapeutics can take a relatively straightforward path when ...